Suchergebnisse - "Hasan, Syed Shahzad"

PubPharm (418)

51

Correction to: Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’

enthalten in: Drugs | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

52

A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches

enthalten in: American journal of cardiovascular drugs : drugs, devices, and other interventions | 2023

von Nwanosike, E. | Sunter, W. | Ansari, M. | +3

53

Comment on: ‘Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know?’

enthalten in: Drugs | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

54

COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients : A Cross-Sectional Study and the Implications for Pakistan and Beyond

enthalten in: Vaccines | 2023

von Amjad, Z. | Maryam, I. | Munir, M. | +8

55

Should COVID-19 be considered cardiovascular disease risk equivalent?

enthalten in: International journal of cardiology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Int J Cardiol. 2023 Feb 1;372:138-143. - PMID 36535564

56

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

57

Anakinra for the prophylaxis of venous thromboembolism in patients with COVID-19

enthalten in: Inflammopharmacology | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

58

Comment on 'The dangers of non-randomized, observational studies. Experience from the COVID-19 epidemic'. Aspirin therapy in COVID-19 : too soon to dismiss its benefits?

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: J Antimicrob Chemother. 2023 Feb 1;78(2):323-327. - PMID 36575642

59

Statin Therapy in COVID-19 : Inhibition of NETosis

enthalten in: Journal of general internal medicine | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: J Gen Intern Med. 2022 Dec;37(16):4144-4152. - PMID 35768681

60

A Real-World Exploration into Clinical Outcomes of Direct Oral Anticoagulant Dosing Regimens in Morbidly Obese Patients Using Data-Driven Approaches

enthalten in: American journal of cardiovascular drugs | 2023

von Nwanosike, E. | Sunter, W. | Ansari, M. | +3